$24.750
+0.020 (+0.08%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
¿Debería comprar acciones de SAV?
Cassava Sciences Inc (SAVA) appears to be a good buy right now, especially considering its current price of 2.38, which is well below its 52-week high of 3.45. The recent closure of the DOJ investigation and the company's strategic rebranding to Filana Therapeutics are positive catalysts that could enhance investor confidence. Additionally, the RSI is at 66.474, indicating strong momentum, while the stock has seen a 16.10% increase over the last 20 days, suggesting a bullish trend. However, the main risk is the company's negative net income, which was -44224000 in Q2 2025, highlighting ongoing financial challenges that investors should monitor closely.
SAV cerró en $24.75 el Monday, tras subir +0.08%
SAV (SAV) last closed at $24.75, gaining +0.08%. These facts feed the 1-day and 1-week SAV price prediction above.
Factores de la previsión
Los factores de la previsión de SAV (SAV) combinan patrones gráficos similares, estacionalidad y medias móviles.
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Análisis de estacionalidad de SAV
Artículos relacionados
- How to Invest in Gold in 2026: A Guide After the Price Pullback and Fed Hike FearsGold fell about 30% from its January 2026 record as Fed hike odds rose. Learn what drives gold, ETFs vs miners, taxes, and a rules-based plan to invest in gold.
- Treasury Yields and the Stock Market: What a Near-5% 10-Year Yield Means for Investors in 2026The 10-year Treasury yield hit 5.31% in October 2026 before easing to 4.88%. Learn how Treasury yields affect stocks, which sectors react and how to plan.
- CPI Report and the Stock Market: How to Read October 2026 Inflation Data Before the Fed DecidesOctober 2026 CPI lands Nov 10 with no year-over-year number and Fed hike odds near 80%. Learn how to read CPI, which stocks react, and how to plan for it.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.